- Diversified Healthcare Trust releases latest performance outlook, expects total revenue (REV) for fiscal year 2026 to grow by approximately 8.0%
- Dragonfly’s Qureshi says crypto built for AI
- Anthony Pompliano's Bitcoin Treasury ProCap Buys Back Stock Amid 85% Price Plunge
- British Pound Forecast: GBP/USD Forms Second Falling Wedge Pattern in 2026
- New York Forex Market: US Dollar Rises Slightly, Safe-Haven Demand Boosts Yen and Swiss Franc
- Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
- Ero Announces Inaugural PEA for Furnas, Outlines Low Capital Intensity Project with a 24-Year Initial Mine Life
- TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
- 22nd Century Group Reports Continued Early Sales Momentum for VLN Cigarette Products
- Annual financial data disclosed by specialty chemicals supplier Quaker Houghton shows that the company’s net sales for the year reached $1.89 billion.
- Astellas Pharma announced a global strategic collaboration agreement with biotechnology company Vir Biotechnology, Inc. The two parties will jointly advance the development of the innovative drug VIR-5500 in the field of prostate cancer treatment.
- JPMorgan's Chief Financial Officer recently stated that the Apple Card, jointly launched with Apple, will not lead to a significant increase in the proportion of subprime cardholders.
- Better and the well-known investment institution Framework Ventures officially announce the establishment of a strategic partnership
- Vir Biotechnology, Inc. announces positive progress in dose expansion cohorts for its research and development projects
- Keysight Stock Rallies After Q1 Earnings Beat Estimates
- February 24 Overseas Headlines: EU Delays Vote on US Trade Agreement, IBM Stock Plunges 13%, Former UK Ambassador to the US Arrested for Misconduct
- Astellas Pharma announces that its collaboration agreement terms could bring in up to $1.37 billion in additional funding.
- The Federal Reserve proposes to explicitly remove reputational risk from bank supervision
- The probability of the Federal Reserve keeping interest rates unchanged in March reaches 96%
- AMC Networks Announces Effectiveness of Amendments to its 10.50% Senior Secured Notes due 2032 and Extension of Consent Solicitation
- Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN 3.9% Rapamycin Anhydrous Gel (QTORIN rapamycin) in Microcystic Lymphatic Malformations
- 'Ethereum Foundation believes in Defipunk', says org as it forms team to support protocol development
- Following earlier actions to remove reputation risk from its supervision of banks, Federal Reserve Board requests comment on proposal to codify that removal
- Tenaris Terminates Second Tranche of its USD 1.2 Billion Share Buyback Program
- Mexican stock market closed down over 1.1%, while Canadian small-cap index rose over 0.5%
- Offerpad (NYSE:OPAD) Reports Q4 CY2025 In Line With Expectations But Stock Drops
- BioMarin Pharmaceutical's (NASDAQ:BMRN) Q4 CY2025 Sales Beat Estimates
- Keysight (NYSE:KEYS) Reports Upbeat Q4 CY2025, Stock Jumps 13.9%
- MediaAlpha (NYSE:MAX) Misses Q4 CY2025 Sales Expectations, But Stock Soars 8.2%
- Chainlink's Taylor Lindman joins SEC as chief counsel for crypto task force
- Top 20 U.S. Stocks by Trading Volume on February 24: IBM Shares Plunge 13%, Core Business Faces AI Threat
- Bitcoin may reverse course and rally to $75K: Here’s how
- ACV Auctions's (NYSE:ACVA) Q4 CY2025 Sales Beat Estimates, Stock Soars
- NEAR launches Near.com super app, featuring AI capabilities and confidential transactions
- Russia earned as much as $1.68 billion by selling 300,000 ounces of gold in January, taking advantage of record-breaking prices.
- Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
- John Bean (NYSE:JBTM) Exceeds Q4 CY2025 Expectations
- Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
- Netflix CEO Claps Back At President Trump: 'This Is A Business Deal, It's Not A Political Deal'
- BWX (NYSE:BWXT) Delivers Impressive Q4 CY2025, Stock Soars
- Primoris (NYSE:PRIM) Surprises With Strong Q4 CY2025 But Stock Drops
- Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%
- Bed Bath & Beyond 'Building the First Everything Home Company' CEO Says In Q4 Shareholder Letter
- Aave’s $50 million funding controversy with ACI Founder Marc Zeller
- JBT Marel Corporation recently released its financial report for the fourth quarter and full year of fiscal 2025, and simultaneously issued its performance guidance for 2026, demonstrating strong confidence in continued business growth.
- According to documents submitted to the U.S. Securities and Exchange Commission (SEC), Tianrui Company officially signed a settlement agreement with software giant SAP on February 19, aiming to fully resolve the legal disputes between the two parties.
- Super Group announces an adjustment to its dividend policy, raising its annual dividend target from the previous $0.16 per share to no less than $0.20 in cash.
- According to the latest filing submitted to the U.S. Securities and Exchange Commission, Joshua Easterly, a key figure at TPG Specialty Lending Inc., is set to officially retire from Sixth Street Partners.
- Thor Industries Inc recently announced a major strategic adjustment to optimize and upgrade its North American operating model.
- Keurig Dr Pepper Inc (KDP) recently announced that its subsidiary, Future Global Coffee Co., plans to raise funds for the remaining payment of its acquisition of a stake in JDE Peet's by issuing long-term debt.
- Boise Cascade (NYSE:BCC) Exceeds Q4 CY2025 Expectations
- Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
- Ultragenyx to Participate at Investor Conferences in March
- Ultragenyx to Participate at Investor Conferences in March
- Addus HomeCare (NASDAQ:ADUS) Reports Q4 CY2025 In Line With Expectations
- Sanofi's (SNY) R&D Track Record Remains Investor Concern, Says BofA
- Truist Lowers Neurocrine Biosciences, Inc.'s (NBIX) PT Following 2026 Outlook Update
- Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- World Liberty Financial draws unwanted attention after ZachXBT teased an upcoming investigation report
- Paymentus (NYSE:PAY) Delivers Strong Q4 CY2025 Numbers But Stock Drops
- Israeli Arrests Over Polymarket Bets Put Prediction Markets On Notice
- Capital One Slips As Private Credit Jitters Spread
- Alphabet Inc. (GOOGL): Loblaw Companies Limited Enters into New Collaboration
- Citi Lowers PT on Broadcom Inc. (AVGO) Stock
- ONEOK Announces Higher Full-Year 2025 Earnings: Net Income up 11%, Adjusted EBITDA up 18%
- DHT Holdings, Inc. secures one-year time charter for DHT Redwood
- European Wax Center, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4th
- FinWise Bancorp Announces Agreement with Albert Corporation to Offer Millions of Americans Transparent, Affordable and Convenient Short-term Personal Loans
- Hims & Hers Health remote pharmacy reports Q4 revenue of $617 million, analysts expected $619.3 million
- Mueller Water Products to Participate in the Gabelli 36th Annual Pump, Valve and Water Systems Symposium
- Goldman Sachs Raises PT on Arista Networks, Inc. (ANET) Stock
- The three major U.S. stock indexes closed sharply lower, with IBM experiencing its largest single-day drop since 2000.
- B. Riley Raises PT on Onto Innovation Inc. (ONTO) Stock
- SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
- Cloudflare, Inc. (NET) Enters into Strategic Partnership with Mastercard Incorporated
- Billionaire Mike Novogratz Explains Why Bitcoin (BTC) Plunged
- Phillips Edison & Company to Present at Citi's 2026 Global Property CEO Conference
- Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
- Great Lakes Reports Fourth Quarter and Full Year 2025 Results and the Signing of Two International Offshore Energy Contracts
- Kaixin Holdings Announces 2026 Annual General Meeting Results
- Something Rare Is Happening In Emerging Markets - And You Are Still Missing It
- Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
- Remitly Announces Upcoming Webinar and Investor Conference Participation
- ROC Announces Closing of Upsized Initial Public Offering
- Robinhood Markets, Inc. to Present at the Citizens Technology Conference on March 2, 2026
- MediaAlpha Announces Fourth Quarter and Full Year 2025 Financial Results
- Sana Biotechnology to Present at March 2026 Investor Conferences
- Blue Gold Aligns Ghana Litigation Strategy Around Ongoing International Arbitration
- ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
- OpenClaw Creator Bans Bitcoin, Crypto Chatter After Joining OpenAI
- Goldman Sachs Initiates Coverage of Credo Technology Group Holding Ltd (CRDO) Stock
- Leidos Holdings, Inc. (LDOS) Releases Financial Results for Q4 2025 and FY 2025
- PROCEPT BioRobotics Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
- Bed Bath & Beyond, Inc. CEO and Executive Chairman Marcus Lemonis issues a letter to shareholders summarizing fiscal year 2025 and providing an outlook for 2026.
- 3 AI Stocks Outpacing NVIDIA in 2026 - With More Upside Ahead
- Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board
- Letter to Stockholders Issued by Diamondback Energy, Inc.
- Astec Announces Quarterly Dividend
- Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program
- PIPPIN price prediction: How AI-memecoin outpaced Bitcoin to post 22% rally
